← Ticker index
ILMN
Ticker
ILMN
Congressional Trades
32
by 5 members
Ticker disclosure brief
Congressional disclosure records for ILMN
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Gilbert Cisneros
BUY · 2026-02-10
Largest range
$1K – $15K
Gilbert Cisneros
Longest observed gap
66d
Lisa McClain
Highest 30d vs SPY
109.0%
Thomas Kean
Purchase rows
17
53%
Sale rows
15
47%
Disclosed midpoint
$256K
range estimate
Unique Traders
5
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats16 · 50%
Republicans16 · 50%
Federal awards
all →- 2026-07-09$39KDepartment of AgricultureILLUMINA BARLEY 50K GENOTYPING ARRAYS
- 2026-07-09$17KNational Aeronautics and Space AdministrationANNUAL MAINTENANCE AND REPAIR PLAN FOR ILLUMINA NEXTSEQ1000
- 2026-07-08$144KDepartment of Health and Human ServicesILLUMINA REAGENT CHEMISTRY KITS
- 2026-07-08$100KDepartment of Health and Human ServicesILLUMINA REAGENT CHEMISTRY KITS
- 2026-07-07$250KDepartment of Health and Human ServicesILLUMINA REAGENT CHEMISTRY KITS
- 2026-07-07$24KDepartment of Health and Human ServicesINFINIUM GLOBAL DIVERSITY ARRAY-8 V1.0 KIT(96 SAMPLES) CAT#20031811 $7,892.10 (PLUS 1.5% SHIPPING) TOTAL: $24,031.45
- 2026-06-30$27KDepartment of Health and Human ServicesNHGRI: 1. NEXTSEQ 2000 BRONZE SUPPORT PLAN
- 2026-06-26$412KDepartment of AgricultureQ4 DELIVERY ORDER FOR WHOLE GENOME SEQUENCING KITS AND ASSOCIATED SUPPLIES WITH ILLUMINA INC. FOR ALL USDA FSIS LABORATORIES UNDER CONTRACT 1232SA25D0004
- 2026-06-25$104KDepartment of the InteriorILLUMINA MISEQ I100 PLUS SYSTEM 70316572
- 2026-06-25$53KDepartment of Health and Human ServicesTHIS ACQUISITION PROVIDES ONE (1) WHOLE GENOME SEQUENCING INSTRUMENT, INCLUDING TRAINING AND A ONE-YEAR MANUFACTURER'S WARRANTY, TO SUPPORT MICROBIOLOGICAL TESTING REQUIREMENTS
Lobbying filings
all →- 2026-05-07$0ILLUMINA INC.FY27 House LHHS & Senate Defense Appropriations in relation to proteomics research.
- 2026-04-20$320KILLUMINA INC.P.L. 118-42 (H.R. 4366 (118th Congress)): Consolidated Appropriations Act, 2024; all provisions Discussions related to National Institutes of Health (NIH) funding Discussions related to U.S. government disease surveillance programs H.R. 7118: Genomic Answers for Childrens Health Act of 2026; all provisions General issues related to trade
- 2026-04-20$80KILLUMINA INC.General issues related to trade.
- 2026-04-20$80KILLUMINA INC.General discussions related to FDA regulation of diagnostics. General discussions related to Medicare reimbursement for diagnostic tests. General trade issues.
- 2026-04-20$60KILLUMINA INC.H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to genomic sequencing; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to artificial intelligence General trade issues
- 2026-04-20$19KILLUMINA INC.Issues related to health care diagnostics NIH Funding
- 2026-04-19$60KILLUMINATE USAIssues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and impl
- 2026-03-12$19KILLUMINA INC.issues related to the National Defense Authorization Act for FY 2025 issues related to health care diagnostics
- 2026-03-09$19KILLUMINA INC.issues related to the National Defense Authorization Act for FY 2025 issues related to health care diagnostics
- 2026-02-11$0ILLUMINATE USAIssues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and implementation or interpretation of applicable regulations impacting U.S.-based manufacturing operations. Issues related to domestic manufacturing of solar energy components, including tax incentives, trade and supply-chain policy, workforce development, energy policy, and impl
Loading trade analytics…
All Disclosed Trades
Page 1 · 25 of 32 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2026-02-10 | DGilbert Cisneros | BUY | $1K – $15K | 28d | receipt → |
| 2026-02-10 | DGilbert Cisneros | BUY | $1K – $15K | 28d | receipt → |
| 2026-02-10 | DGilbert Cisneros | BUY | $1K – $15K | 27d | receipt → |
| 2026-02-10 | DGilbert Cisneros | BUY | $1K – $15K | 27d | receipt → |
| 2026-01-29 | DRo Khanna | SELL | $1K – $15K | 8d | receipt → |
| 2026-01-29 | DRo Khanna | SELL | $1K – $15K | 8d | receipt → |
| 2025-10-30 | RLisa McClain | BUY | $1K – $15K | 25d | receipt → |
| 2025-10-30 | RLisa McClain | SELL | $1K – $15K | 25d | receipt → |
| 2025-10-31 | RLisa McClain | SELL | $1K – $15K | 24d | receipt → |
| 2025-10-30 | RLisa McClain | SELL | $1K – $15K | 22d | receipt → |
| 2025-10-31 | RLisa McClain | SELL | $1K – $15K | 21d | receipt → |
| 2025-10-30 | RLisa McClain | SELL | $1K – $15K | 22d | receipt → |
| 2025-10-31 | RLisa McClain | SELL | $1K – $15K | 21d | receipt → |
| 2025-10-30 | RLisa McClain | BUY | $1K – $15K | 22d | receipt → |
| 2025-10-30 | RLisa McClain | BUY | $1K – $15K | 22d | receipt → |
| 2025-06-09 | RLisa McClain | BUY | $1K – $15K | 66dApparent delay | receipt → |
| 2025-06-09 | RLisa McClain | BUY | $1K – $15K | 65dApparent delay | receipt → |
| 2025-06-09 | RLisa McClain | BUY | $1K – $15K | 65dApparent delay | receipt → |
| 2025-04-01 | RThomas Kean | BUY | $1K – $15K | 44d | receipt → |
| 2025-04-01 | RThomas Kean | BUY | $1K – $15K | 44d | receipt → |
| 2025-02-25 | DRo Khanna | SELL | $1K – $15K | 9d | receipt → |
| 2025-02-25 | DRo Khanna | SELL | $1K – $15K | 9d | receipt → |
| 2024-07-02 | DRo Khanna | SELL | $1K – $15K | 36d | receipt → |
| 2024-07-02 | DRo Khanna | SELL | $1K – $15K | 36d | receipt → |
| 2024-05-29 | DRo Khanna | BUY | $1K – $15K | 7d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.